Sabine Yerly

19.5k total citations
195 papers, 7.7k citations indexed

About

Sabine Yerly is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sabine Yerly has authored 195 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Infectious Diseases, 138 papers in Virology and 44 papers in Epidemiology. Recurrent topics in Sabine Yerly's work include HIV Research and Treatment (137 papers), HIV/AIDS drug development and treatment (117 papers) and HIV/AIDS Research and Interventions (101 papers). Sabine Yerly is often cited by papers focused on HIV Research and Treatment (137 papers), HIV/AIDS drug development and treatment (117 papers) and HIV/AIDS Research and Interventions (101 papers). Sabine Yerly collaborates with scholars based in Switzerland, United States and France. Sabine Yerly's co-authors include Luc Perrin, Bernard Hirschel, Laurent Kaiser, Huldrych F. Günthard, Lionel Perrin, Viktor von Wyl, Thomas Klimkait, Philippe Bürgisser, Jürg Böni and Pietro Vernazza and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Sabine Yerly

187 papers receiving 7.5k citations

Peers

Sabine Yerly
Rob Schuurman Netherlands
Keith Henry United States
Jeffrey Chodakewitz United States
Vincent Cálvez France
Kathleen Squires United States
Richard C. Reichman United States
Richard T. D’Aquila United States
Phyllis J. Kanki United States
Monique Nijhuis Netherlands
Françoise Brun‐Vézinet France
Rob Schuurman Netherlands
Sabine Yerly
Citations per year, relative to Sabine Yerly Sabine Yerly (= 1×) peers Rob Schuurman

Countries citing papers authored by Sabine Yerly

Since Specialization
Citations

This map shows the geographic impact of Sabine Yerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Yerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Yerly more than expected).

Fields of papers citing papers by Sabine Yerly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Yerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Yerly. The network helps show where Sabine Yerly may publish in the future.

Co-authorship network of co-authors of Sabine Yerly

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Yerly. A scholar is included among the top collaborators of Sabine Yerly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Yerly. Sabine Yerly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yerly, Sabine, Paloma Parvex, Nathalie Rock, et al.. (2024). Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection. Pediatric Allergy and Immunology. 35(5). e14161–e14161.
2.
Courjon, Johan, Sabine Yerly, Pauline Vetter, et al.. (2023). Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infectious Diseases. 10(12). ofad595–ofad595. 1 indexed citations
3.
4.
Masouridi‐Levrat, Stavroula, Léna Royston, Sabine Yerly, et al.. (2023). Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases. 78(2). 423–429. 9 indexed citations
5.
Amari, Emmanuelle Boffi El, Manuel Schibler, Frédérique Jacquérioz, et al.. (2023). A Case of Mpox Reinfection. Clinical Infectious Diseases. 77(1). 135–137. 27 indexed citations
6.
Nguyen, Huyen, Christian Thorball, Jacques Fellay, et al.. (2021). Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link. eLife. 10. 4 indexed citations
7.
Jacquérioz, Frédérique, Stéphanie Baggio, Angèle Gayet‐Ageron, et al.. (2021). Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study. BMJ Open. 11(6). e044242–e044242. 6 indexed citations
8.
Baggio, Stéphanie, Arnaud G. L’Huillier, Sabine Yerly, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases. 73(1). 148–150. 73 indexed citations
9.
Wandeler, Gilles, Sabine Yerly, Annalisa Marinosci, et al.. (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial. PLoS Medicine. 17(11). e1003421–e1003421. 20 indexed citations
10.
Scherrer, Alexandra, Viktor von Wyl, Wan-Lin Yang, et al.. (2016). Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clinical Infectious Diseases. 62(10). 1310–1317. 39 indexed citations
11.
Vetter, Beatrice, Katrien Fransen, Christoph Niederhauser, et al.. (2014). Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests. PLoS ONE. 9(10). e111552–e111552. 12 indexed citations
12.
Castro, Erika, Donatella Ciuffreda, Philippe Bürgisser, et al.. (2010). HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland. AIDS Research and Human Retroviruses. 26(11). 1233–1238. 11 indexed citations
13.
Wyl, Viktor von, Maryam Ehteshami, Jori Symons, et al.. (2010). Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase. The Journal of Infectious Diseases. 201(7). 1054–1062. 23 indexed citations
14.
Yerly, Sabine, Thomas Junier, Angèle Gayet‐Ageron, et al.. (2009). Impact of newly HIV diagnosed individuals on the transmission of drug resistance. Antiviral Therapy. 14(4).
15.
Yerly, Sabine, Thomas Junier, Huldrych F. Günthard, et al.. (2008). Drug resistance in newly HIV diagnosed individuals: transmission rate, clusters and persistence. Antiviral Therapy. 13. 2 indexed citations
16.
Garbino, Jorge, Margaret W. Gerbase, Werner Wunderli, et al.. (2004). Lower Respiratory Viral Illnesses. American Journal of Respiratory and Critical Care Medicine. 170(11). 1197–1203. 110 indexed citations
17.
Marcelin, Anne‐Geneviève, Jacques Reynes, Sabine Yerly, et al.. (2004). Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20. AIDS. 18(9). 1340–1342. 29 indexed citations
18.
Bart, Pierre‐Alexandre, Jean‐Yves Meuwly, Jean-Marc Corpataux, et al.. (1999). Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. AIDS. 13(12). 1503–1509. 12 indexed citations
19.
Yerly, Sabine, et al.. (1998). Switch to an unusual amino acid at codon 215 of the HIV-1 reverse transcriptase gene in seroconverters infected with zidovudine resistant variants.. UCL Discovery (University College London). 3 indexed citations
20.
Yerly, Sabine, Sabine Kinloch-de-Loës, Peter Erb, et al.. (1996). PREVALENCE DE LA TRANSMISSION DE VIRUS RESISTANT A LA ZIDOVUDINE EN SUISSE. Schweizerische medizinische Wochenschrift. 126(43). 1845–1848. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rob Schuurman Breakdown of academic impact, for papers by Keith Henry Breakdown of academic impact, for papers by Jeffrey Chodakewitz Breakdown of academic impact, for papers by Vincent Cálvez Breakdown of academic impact, for papers by Kathleen Squires Breakdown of academic impact, for papers by Richard C. Reichman Breakdown of academic impact, for papers by Richard T. D’Aquila Breakdown of academic impact, for papers by Phyllis J. Kanki Breakdown of academic impact, for papers by Monique Nijhuis Breakdown of academic impact, for papers by Françoise Brun‐Vézinet
Rankless by CCL
2026